These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli. Watanabe T. Jpn J Exp Med; 1969 Dec; 39(6):631-47. PubMed ID: 4914751 [No Abstract] [Full Text] [Related]
6. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations. Institóris L, Horváth IP, Csányi E. Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481 [No Abstract] [Full Text] [Related]
7. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations]. Maliugina LL, Pol'kina RI. Vopr Onkol; 1974 Feb; 20(3):62-9. PubMed ID: 4439803 [No Abstract] [Full Text] [Related]
11. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds]. Ivanitskii LP, Makukho LV. Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738 [No Abstract] [Full Text] [Related]
16. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours. Kellner B, Németh L, Sugár J, Gáti E, Pályi I, Döbrössy L. Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384 [No Abstract] [Full Text] [Related]